Selling Our Children to the Pharmaceutical Industry - PBS reports

Selling Our Children to the Pharmaceutical Industry - PBS reports

Have we sold our kids to the pharmaceutical Industry? This PBS report appears to be evidence that foster kids have been not just used, but abused as cash cows for exactly this purpose...corrupted doctors who have forgotten they took an oath to do no harm, not to profit as much as possible. Medicine has lost it's way, and they are not going to change direction until we make them change direction. Watch this video and then read this supposed Sham  Torture study in 4 to 6 year old toddlers using seroquel. This is a precursory study leading to a much larger study planned in the future.
Yes, you could have guessed that it was directed out of Massachusetts General Hospital ( Janet Wozniak, MD ). Most in the know consider this Harvard University affiliated Hospital the center and birth place of the "BIPOLAR CHILD" Myth.

Please keep in mind as you read this study that there is no stated criteria for preschool bipolar disorder in the DSM-IV. The well funded Pharmaceutical Industry shill doctors @ Harvard created this criteria out of thin air to get drug approval from the FDA. Then using this witchcraft logic, come to the conclusion that the if the FDA approves the drug, then there must be a validated disease?

I have a really hard time following this sick and twisted bullshit logic that is putting thousands upon thousands of our children at dire risk; but I guess when billions of dollars in profits are at stake...Magic is made possible...

Watch the full episode. See more Need To Know.

http://clinicaltrials.gov/pediatric+quetiapine

 Quetiapine for Mania In Preschool Children 4 to 6 Years of Age With Bipolar Disorder

This study has been completed. 

 Purpose

This is an 8-week open-label study aimed at assessing the effectiveness and tolerability of Quetiapine, in the treatment of preschool children aged 4 to 6 years with bipolar and bipolar spectrum disorder. This is an exploratory, pilot study, seeking to determine whether Quetiapine is efficacious and well tolerated in the treatment of preschoolers with pediatric bipolar and bipolar spectrum disorder in this age group. The study results will be used to generate hypotheses for a larger randomized controlled clinical trial with explicit hypotheses and sufficient statistical power.

Official Title: Open-Label Study of Quetiapine for Mania In Preschool Children 4 to 6 Years of Age With Bipolar and Bipolar Spectrum Disorder

Primary Outcome Measures:

• reductions in symptoms measured by [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
  
• Young-Mania Rating Scale (Y-MRS) [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
  
• Mania Symptom Checklist [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
  

Estimated Enrollment:	20
Study Start Date:	February 2005
Study Completion Date:	April 2009
Primary Completion Date:	April 2009 (Final data collection date for primary outcome measure)

Intervention Details:

Drug: quetiapine (Seroquel)
2.5 - 5.0mg/kg PO BID quetiapine

Detailed Description:

Seroquel is a psychotropic agent that affects multiple neurotransmitter receptors in the brain: serotonin 5HT1A and 5HT2, dopamine D1 and D2, histamine H1 (IC50=30nM), and adrenergic receptors.

This is an 8-week open-label study aimed at assessing the effectiveness and tolerability of Quetiapine, in the treatment of preschool children aged 4 to 6 years with bipolar and bipolar spectrum disorder. This is an exploratory, pilot study, seeking to determine whether Quetiapine is efficacious and well tolerated in the treatment of preschoolers with pediatric bipolar and bipolar spectrum disorder in this age group. The study results will be used to generate hypotheses for a larger randomized controlled clinical trial with explicit hypotheses and sufficient statistical power.

  Eligibility

Ages Eligible for Study:	4 Years to 6 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

• Male or female subjects, 4-6 years of age.
• Subjects must have a DSM-IV diagnosis of bipolar I, bipolar II disorder or bipolar spectrum disorder and currently displaying manic, hypomanic, or mixed symptoms (with or without psychotic features) according to the DSM-IV based on clinical assessment and confirmed by structured diagnostic interview (Kidd Schedule of Affective Disorders and Schizophrenia Epidemiological Version). Bipolar spectrum disorder (or sub-threshold bipolar disorder) is operationalized as having severe mood disturbance, which meets DSM-IV Criteria A for bipolar disorder but meet fewer elements in criteria B (only require 2 items for elation category and 3 for irritability).
• Subjects and their legal representative must have a level of understanding sufficient to communicate intelligently with the investigator and study coordinator, and to cooperate with all tests and examinations required by the protocol.
• Subjects and their legal representative must be considered reliable.
• Each subject and his/her authorized legal representative must understand the nature of the study. The subject's authorized legal representative must sign an informed consent document.
• Subjects must have an initial score on the Y-MRS total score of at least 20.
• Subject must be able to participate in mandatory blood draws.
• Subjects with comorbid ADHD, ODD, CD, anxiety and depressive disorders will be allowed to participate in the study provided they do not meet for any of the exclusionary criteria.
• For concomitant stimulant therapy used to treat ADHD, subjects must have been on a stable dose of the medication for 1 month prior to study enrollment. The dose of the stimulant therapy will not change throughout the duration of the study.

FDA Clinical Summary Review of Pediatric Metabolic Adverse Events 5 Atypical Antipsychotics:Seroquel -48 adverse events, 5 deaths, 36 kids developed/experienced diabetes

      Destiny Hager dead @Age 3                                                            Rebecca Riley dead @Age 4

FDA Clinical Summary Review of Pediatric Metabolic Adverse Events 5 Atypical Antipsychotics:Seroquel -48 adverse events, 5 deaths, 36 kids developed/experienced diabetes

 We are destroying our children in the name of corporate profits & greed...We are burying children in the name of egocentric false medicine concerned more with reputations, money, or status; than with the lives they have sworn an oath to care for.

DO NO HARM

Remember these are just a few of the reported adverse events in 2008-2009. There is little doubt thousands upon thousands of children are suffering the horrible and debilitating side effects of seroquel and like drugs today as these words are being typed.

There are not names next to these statistics listed below; but these are very real children...they could be your neighbors children, a relatives child, a friends child, they could be poor or foster children; and they all have something in common, they have names...they are America's children.

Read what these very young kids & toddlers are being given...it's disturbing and beyond all rational comprehension....

FDA Clinical Summary Review of Pediatric Metabolic Adverse Events 5 Atypical Antipsychotics

Summary Table: Clinical Review of Serious and Non-serious Pediatric Metabolic Adverse Event (AE)
Reports for 5 Atypical Antipsychotic Drugs from FDA AERS Database 1-Year Time period: 9/1/08-8/31/09
Metabolic Adverse Events
Seroquel (quetiapine fumarate)
48
20 Males
28 Females
6-17 years
5 deaths (no causal association reported)
13 reports weight gain with specific mention of weight gain
36 reports stating child developed/experienced or had diabetes
1 underwent gastric bypass surgery
---------------------------------------------------------------

Seroquel (quetiapine) Metabolic Adverse Events (n=48)

11yo F Death
Anxiety and ADHD
Death. BMI 28.3. Seroquel treatment started in 2001. 5/5/03 Patient died of complications of DM & DKA.
methylphenidate, prednisolone, amoxicillin, termazepam, clonidine, burpropion, diphenhydramine, ibuprofen, cyclobenzaprine

16yo M
Death
Seroquel as sleep aid
Death. Patient experienced DM and pancreatitis in 1/1981 (prior to marketing of Seroquel) DKA 4/05 neuropathy and death (no date reported) male with PMH DM 1, hypertension, hepatitis C, iv drug abuse, recurrent pancreatitis, respiratory distress, bilateral strokes, hypercholesterolemia, arthritis, hypothyroid, cerebritis, Took Seroquel for sleep aid 4/4/5. History psych disorder confusion episodes, argumentativeness, combativeness,
lonazepam, pantoprazole, clonidine, simvastatin, citalopram, metoprolol, insulin, senna, hydralzine, lorazepam, ketorolac, tromethamine, lisinopril, ASA

16yo F
Death
Aggression history of autism, obesity & violent outbursts
Death Patient developed DM and diabetes-related conditions. Patient died due to shock, DKA, pancreatitis and tardive dyskinesia. Hospitalized in 9/04 with pain, vomiting, hi blood glucose. Discontinued with DKA. Blood Glucose 990, info died due to pancreatitis, DKA, shock. Autopsy revealed new onset diabetes, DKA, pulmonary congestion & edema, hepatomegaly with metamorphosis, Seizure episode. PMH Landau-Kleffner syndrome, autistic disorder, severe MR, near global aphasia, intermittent constipation probably related to dietary factors, encopresis, chronic sleep difficulties, weight gain, and premenstrual syndrome with rage behaviors.
clonidine, sertraline, diazepam

15yo F
Death
Depression, agitation, somnolence, tremor, dyskinesia
Death Patient began Seroquel 12/05 and within 8 months found dead on bedroom floor. Autopsy revealed death from possible fatal heart arrhythmia. No prior cardiovascular disease. After suicidal gesture, Dr increased dose and Patient became increasingly agitated, gained 50lbs, experienced neck rigidity, tremor in hands, uncontrollable movements & weakness.
NI

15yo M
Death
OCD, behavior concerns, Chiari Malformation, and possible history of PANDAS
Death. For at least several months after lithium started months recently. 3d history of respiratory symptoms, muscle rigidity, dysphasia and confusion. 1/18/09 Patient difficult to arouse. 911 call and taken to ER. Intubated and respiratory failure. Symptoms of hyperglycemia, rash, prolonged QT, hypotension & hyperthermia. Presumed diagnosis of neuroleptic malignant syndrome. Patient suffered severe HIE, brain function deteriorated and Patient died.
quetiapine, fluvoxamine, lithium

6yo M
ADHD, Bipolar & OCD
PMH hyperglycemia treated in 2000, BMI=35.9 AEs considered non-serious; developed DM & hyperglycemia. PMH liver, high cholesterol, thyroid, depression, ADHD, obesity
clonidine cefprozil

7yo M
Bipolar Disorder and Depression Affective Disorder
Alleged that patient developed DM from Seroquel.
Risperidal, Abilify

8yo F
Bipolar Disorder
Grandmother reports that 8yo treated with Seroquel and became lethargic weight gain 4-5 lbs in a month
Trileptal, Seroquel, Benadryl

8yo F
Hosp
Mood disorder
History of depression, bipolar disorder, ADHD. BMI 21.5. history of pulmonic stenosis, ASD, treatment for this age 2 yrs. Started Seroquel treatment 3/30/04 then on 4/27/04 to ER for suicidal ideation. 2/6//06 hosp & DM 1 discharged with blood sugar 304 mg/dl, urine glucose >1000mg/dl
risperidone, topiramate, fluoxetine

9yo M
NI
Patient had significant hallucinations, being touched hearing voices, seeing things, paranoia. Urinating on floor while sleeping. Violent outburst and disruptive behavior. Severe panic attacks. Significant weight gain. Suicide Ideation
NI

11yo M
Depression, Anxiety
Seroquel started 2003 experienced DM and DKA Also Bell’s Palsy.
NI

11yo M
Bipolar Disorder
Seroquel began 4/9/09 Patient experienced hypertension
amphetamine, clonidine

12yo F
Schizophrenia, Depression, Bipolar Disorder
Seroquel began 7/04 and developed DM in ’05 and Patient developed obesity, DM and pancreatitis in ’06.
ziprasidone

12yo F
Bipolar disorder psychosis and mood stability
Seroquel for bipolar Patient treated Seroquel dose 25-1400 mg for psychosis and mood stability. 2003 attempt suicide, DM II started in 2006 and weight gain in 2005. Medical records reveal earliest 10/02 and stop 7/06 confirmed in med records. Multiple hosp 2004-06 for aggression, suicidal risk, psychosis, in 5/06 borderline prolonged QT
risperidone, aripiprazole and ziprasidone, oxcarbazepine, lamotrigine, Adderall, valproate, methylphenidate, clonidine, dexmhethylphenidate, oloanzapine, trazodone, bupropion. lithium, lorazepam

12yo F
Hosp
NI
Stated 4/04 began treatment and developed DM 2/05. Hospitalized for DM and hypothyroid in 2/05. BMI 18.9. In 2005 treated for diabetic coma and DKA. DM I and Hashimoto’s thyroiditis.
sertraline, escitalopram, topiramate.

12yo F
Bipolar Disorder, with psychotic features, ODD Mild MR
Developed DM and related illnesses. BMI 27.4; medical records give history of being on Seroquel 10/97 developed illness ’99. suicidal, etc History of bipolar, paranoia, depression
NI

12yo F
Bipolar Disorder and Depression
BMI is 53.8; DM, obesity and Neuroleptic Malignant Syndrome started in 2001. Treatment then stopped. Medical records indicate DM I and psychosis NOS. morbid obesity
Abilify, clozapine, ziprasidone, haldol, risperidone, chlorpormazine, olanzapine

12yo M
Basal Ganglion Degeneration
Mom sends in report, son gained ~10lbs a month, with high liver count and in 2007 diagnosed with thyroid disorder. Dr discharged him with Basal Ganglia was taking lithium and Seroquel at same time and was overdosed at Strong Memorial Hospital last year.
lithium

12yo M
Bipolar Disorder, ADHD
Patient treated with Seroquel for ~8years takes Seroquel at night. 9/08 high blood glucose and put on diabetic meds. Mom attributes diabetes and hypertension to the drug. Threatened suicide several times.
NI

13yo F
Depression and Affective Disorder
Developed generalized edema, swollen tongue, on increased dose of 10 mg Abilify for depression. Also dysarthria. While taking Seroquel gained 10 lbs in 2 wks.
NI

13yo F
Depression and Bipolar Disorder
Began treatment 4/13/05 Patient experienced DM 2 in 7/06 and severe weight gain and acute metabolic syndrome.
Wellbutrin, Risperidal, Depakote

13yo F
Hosp
Bipolar Disorder, depression, anxiety
Began treatment 04 and diagnosed DM 2005, obesity with BMI 45.4. acute ER visits and hospitalization
NI

13yo M
Suicidal Depression, Bipolar Disorder
Developed insulin-dependent DM 2 yrs after treatment began age 13 1998 and DM diagnosis 2000. Developed DM and DKA 8/2000 Earliest treatment Seroquel noted 12/1999
lithium, paroxetine, valproate. amox, mirtazapine, escitablopram, citalopram, docusate, salbutamol, insulin, isophane, methylphenidate, heparin, fexofenadine, psuedoephedrine

13yo M
Mild to moderate anxiety; discontinued with generalized anxiety disorder. Impulsive, hostile, suicidal
Report alleged that Risperidone caused Patient to deteriorate psychiatrically 11/01-11/02 and also hospitalized for akathisia. Developed signs and symptoms of hyperprolactinemia which caused pt to have bilateral mastectomy; Patient had preadolescent gynecomastia. meds included sertaline and clonidine. High cholesterol 324; testosterone <20 ng/dl (normal range 241-827); Dr’s assessment preadolescent gyenecomastia. Dr noted no other meds that could relate to gyenecomastia except sertraline. Hospitalized ICU for diabetic ketoacidosis. Discharged with new onset diabetes.
risperidone, sertaline clonidine

13yo M
NI
HAND SURGERY, DIABETES His body mass index was 33.4.). Patient experienced diabetes which started during 2004 and hand surgery which started during 2007.
NI

13yo M
Hosp
Asperger's Syndrome
Experienced self-injurious behavior suicidal ideation, impulsive behavior, DM, high blood cholesterol triglyceride, vomiting, sleep disorder, food craving, high blood glucose. Pt hospitalized.
duloxetine, ziprasidone, diphnhydramine, paracetamol, phenylpropanolamine

13yo M
Anxiety and obsession symptoms
Treated with Seroquel for sleep aid 25 mg from 8/05-11/05. DM began 11/05. Other suspect drug was Abilify started 11/05 2.5-5 mg for agoraphobia but discontinued 11/05 due to hyperglycemic ketoacidosis; diabetic DKA glucose=660; blurred vision, urine frequency, etc. Medical history hepatitis B, sinusitis, sexually molested, adjustment disorder, phobia
fluoxetine for mood, anxiety, OCD, paroxetine for anxiety and agoraphobia

14yo F
ADHD, MR, Seizures, developmental delay, seizures on EEG, acid reflux, mood disorder, adjustment disorder, intermittent explosive disorder, oppositional disorder and increased blood glucose
Alleged report of diabetes as a result of Seroquel. Risperdal and Zyp0rexa. All 3 drugs from 3/04 to 6/04 for unspecified indication. 2004 experienced DM. med records 4/02-6/04 and pharmacy records 6/06. 13yo treated Weights: 3/02 128lb; 4/02 136lbs, 3wks later weight gain and discontinued Depakote and Zyprexa. 8/02 144lb 1/04 edema of hands and legs. Placed on Remeron for rest/mood in 2/04 and 7/05 glucose elevated. Seroquel started after olanzapine and valproate discontinued.
oxcarbazeoine clonidine venlafaxine, methylphenidate, valproate, fluoxetine, oxcarbazepine, paroxetine, ranitidine, clonazepam. Risperdal Zyprexa

14yo F
Depression
Patient developed diabetes and DKA. Diabetes onset was reportedly 1999 5yrs pre Seroquel but DKA 2005-6
NI

14yo F
Major depressive disorder, schizoaffective disorder, obesity, alcohol abuse, poly-substance abuse
Alleged report that female received risperidone on company suspect included olanzapine and Seroquel. No risperidone 2000-2007. Glucophage dispensed 12/00 and insulin dispensed beginning 9/04 Patient diagnosed with on insulin dependent DM. later had suicidal attempt, intentional overdose. Medical history Cushing’s syndrome
risperidone, olanzapine

14yo M
Bipolar Disorder, ADHD
Alleged DM after Seroquel. Had high cholesterol obesity, BMI 30.8 DM started 9/03 and chest pain 9/03
halopol, risperidone, chlorpromazine, olanzapine

14yo M
Schizophrenia
Patient experienced DM I starting in 2004. Med records reveal earliest date Seroquel 5/5/02. 14 yrs old at first event hospitalized 10/03 for psych disorders d/c 11/03 Dec 04 increased WBC 21.7 non-serious events, chest congestion, and hypertension. Following serious psych events schizophrenia, paranoid, impulse control disorder. Tourette syndrome, mild MR, pneumonia, obesity, asthma developmental delays, tonsillectomy, tubes in ears adenoidectomy. Psych history Schizophrenia, autism ADHD
methylphenidate, paroxetine, haloperidol, risperidone, phenobarbital, ziprasidone, Metformin, dipropylline, guaifenesin, hydrocortisone Geodon

16yo F
Hosp
NI
15 lb weight gain in 1 month after starting. Serious adverse event as Patient was hospitalized. Seroquel.
Klonopine (clonazepam)

16yo F
Mood instability, irritability
Treated with Seroquel for mood instability irritability and anger. Developed DM 10/02; BMI 304 weight gain and asthma ’05; obesity started in ’02. Med records 10/02 polyuria, polydypsia, PCO
ripseridone

16yo F
Schizophrenia
Borderline DM with 50 lb weight gain in past year after starting Seroquel.
risperidone lithium, topiramate, tranmolol, venlagaxine, hexacholesterolophene

16yo F
Bipolar Disorder
Blood Glucose increased up to 500 Patient taking Seroquel for past 6-8 months. Patient now on insulin. She had been on Zyprexa for a period of time and gained weight so was switched to Seroquel.
lamotrigine, sertraline. Zyprexa, Prozac

16yo F
NI
Increased triglyceride 500mg/ml. treated with Seroquel. After starting treatment unknown date had increased triglycerides starting 4/08. Seroquel was stopped and triglycerides dropped to 199.
lithium, aripiprazole.

16yo M
Hosp
ADHD; Bipolar Disorder anxiety
Hospitalized x 3 days fainted at school. Suicidal thoughts hypertension, suicidal ideation with intermittent depression.
modafinil; lamotrigine; escitalopram

17yo F
Depression PTSD
BMI=40.2 history of obesity. Seroquel 4/04 also 3/05; previous report stated start 3/04-1/05 weight gain 9/05 and 2/06 DM II; glucose intolerance 2/06 dysmetabolic syndrome 5/06 gastric bypass 8/06
risperidone

17yo F
Psychological problems
Seroquel began 2/02 dose not provided. DM insulin dependent began ~7/03 to ~10/04
buspirone, trazodone

17yo F
Bipolar Disorder
Seroquel since 2002 100mg for bipolar; experienced heart and DM problems in 2004. The patient's Body Mass Index was 30.9.
aripiprazole, clozapine and topiramate

17yo F
Hosp
Psychotic Disorder
Seroquel for psychoses and Seroquel XR. These were taken at various times outpatient and inpatient hospitalizations. Patient experienced increased weight, as well as lipid & metabolic profile.
lithium

17yo F
Hosp
Psychiatric history, psychosis NOS, depressed mood and schizoaffective disorder
Increase in schizophrenia and depression from 1/1999 to 12/06. Diabetes began 9/06. Medical records state: sickle cell trait & smoking. 11/05 had thoughts of death, depression, experienced hallucinations, agitation and was hospitalized. medical records reveal psych disorders, thryomegaly, menorrhagia, hallucinations.
aripiprazole, doxycycline, promethazine, metacclopromide, ethinlestradiol, norgestimate, medroxyprogesterone, prednisolone, hyoscyanine, acyclovir, famotidine, phenoxymethyl penicllin.

17yo M
Depression
Schizophrenia Bipolar disorder Diabetic Coma, DKA, Glycosuria, hyperglycemia, High triglyceride high cholesterol, Obesity, pancreatitis, neuroleptic malignant syndrome, tardive dyskinesia, BMI 39.6 developed diabetes 2 yrs
NI

17yo M
History schizophrenia, bipolar, depression, high cholesterol, high triglyceride, obesity, ETOH use
Developed gall stones and pancreatitis in 12/03. developed DM
Seroquel, Zyprexa risperidone

17yo M
Bipolar Disorder
Patient had a history of high triglycerides, obesity and alcohol use. The patient started quetiapine treatment on 10-Nov-2005. Experienced diabetic ketoacidosis, which started on 27-Oct-2002 and diabetes which started on 27-Oct-2002.
olanzapine aripiprazole and ziprasidone hydrochloride.

17yo F
NI
History included depression. Her body mass index was 21.6.The patient experienced diabetes and diabetic
ketoacidosis
insulin human, desonide, promethazine, insulin glargine, metoclopramide, Ortho tricyclen , metformin hydrochloride, Ortho EVRA patch Novolog mix Prenatal vitamin ferrous sulfate

17yo F
Sleep aid
Patient experienced diabetes and diabetic Ketoacidosis.
NI

When do we say enough is enough?

Johnson and Johnson to pay South Carolina 327 million over Risperdal - Is AstraZeneca Seroquel Next?

Johnson and Johnson to pay South Carolina 327 million over Risperdal Violations - Is AstraZeneca's Seroquel next to Face substantial penalties?

From Bloomberg News:
bloomberg.com/newsj&j-ordered-to-pay-327-million-on-deceptive-marketing-claims

A Johnson & Johnson (JNJ) unit was ordered by a South Carolina judge to pay more than $327 million in penalties for deceptively marketing the antipsychotic drug Risperdal as safer and better than competing medicines.
J&J’s Ortho-McNeil-Janssen Pharmaceuticals unit repeatedly violated the state’s consumer-protection laws by sending a 2003 letter to doctors touting Risperdal as superior to rival drugs and including deceptive information in the product’s warning label, Judge Roger Couch in Spartanburg, South Carolina, concluded.
The drugmaker’s executives “allowed the profit-at-all- costs mentality to cloud” their judgment in connection with the drug’s marketing campaign and its labeling, Couch said in his 17-page ruling.

______

South Carolina has been one of the few states that has not come to a cover up settlement agreement with AstraZeneca over their illegal business practices. Could this be the straw that finally breaks this Camel AstraZeneca's sleazy legal hard ball back. It's been long over due that AstraZeneca be found guilty of their unconscionable illegal practices and be held accountable as the criminal corporation they are.

South Carolina vs AstraZeneca 

AstraZeneca's Seroquel - The message the public and media needs to hear - NOT SETTLED

AstraZeneca's Seroquel - The message the public and mainstream media needs to hear - NOT SETTLED

You may have read about the United States Department of Justice 520 million dollar settlement with AstraZeneca's Seroquel for illegal off label promotion and fraud. Pharmaceutical Giant AstraZeneca to Pay $520 Million for Off-label ... (No Admission of guilt)

You may have also read that numerous States have recently settled over AstraZeneca's Seroquel illegal practices for an additional 68.5 million dollars AstraZeneca paying $68.5M in Seroquel settlement (No Admission of Guilt)

You may have also read that AstraZeneca has settled in civil litigation with an estimated 26,000+ plaintiffs injured by Seroquel for 350 million or somewhere between 11-25 thousand dollars before deductions which are somewhere in the estimated neighborhood of 50%. (No Admission of Guilt)

What you may not know: Is that a high number of the plaintiff's in this litigation will refuse this insulting settlement offer leaving a strong possibility that these cases may be left in temporary limbo for a protracted length of time.

No injured plaintiffs (I know of) have ever been consulted with regards to the secret settlement mediation between AstraZeneca legal counsel and multiple plaintiff law firms. In fact the actual injured party's have been left completely in the dark regarding any details regarding this (Deemed done) reached settlement deal.
To further complicate matters, many of the plaintiff firms have in advance told their clients that this undisclosed amount offer was a take it or leave it proposition; making it absolutely clear they would be no longer representing their clients if they did not accept this secret undisclosed offer that they negotiated without any injured parties input or knowledge.

Plaintiff law firms have been making misleading statements & promises to their clients since late 2010 repeatedly (with one example being statements to the effect of: "the settlement offer packets will be arriving in three weeks to 2 months" since late 2010). The majority of injured plaintiffs still have not received an offer or packet to even refuse/turn-down at this juncture.

What you also may not know: is that by accepting this offer plaintiffs will be relieving AstraZeneca of all future medical needs & cost.

In fact the American Tax Payer will be bearing the cost for a very large number of Seroquel victims care for many years and decades to come. That is the real medicare/medicaid fraud and crimes that will be propagated by AstraZeneca that will continue to linger in the ominous shadows for us all.

That 520 million dollar get out of jail free card AstraZeneca paid the Federal government over off label marketing and medicare fraud cost will appear like a single grain of sand on a very long beach when those cost are finally calculated. 

That in a nut shell is the dog and pony show the American Citizen receives when we as a nation & people allow mega multinational pharmaceutical corporations to control/influence our entire medical system from Congress to Main-street and everyplace in-between with a profit first and above all else business model.

Don't take my word for it; follow those links on the side bar, read, learn, investigate, and see what dire circumstances we have allowed ourselves to be placed under by medical capitalism gone mad.

You might wonder how many mainstream media outlets will run or report that story...or will they more likely just continue to stay eerily silent while collecting huge amounts of advertizing revenues from the Pharmaceutical Industry.

It's far past time to draw the line in the sand and say enough is enough....no more! We will fight, and we will continue to fight for justice...for fairness...for what is right...until there is no one left to fight on...

A place for Seroquel Victims to tell their Story and to seek Justice

Many thousands of People have been forever harmed by AstraZeneca's Seroquel. Many have been involved in litigation for years and are now seeking to express the disappointment & betrayal they have experienced by the secrecy and misinformation they have received from their legal representation. A large percentage of those plaintiffs are refusing to accept an insulting settlement offer rumored to be between 11 - 25 thousand dollars minus fees for life long debilitating injuries caused by Seroquel. 

This blog is a place to share your story, to start holding all those in this litigation accountable, to organize victims & advocacy efforts, and to bring public awareness to the fate of those harmed and maimed by unscrupulous pharmaceutical corporations & unethical attorneys.

This blog is a place where all victims of Seroquel can fight for reasonable justice. I encourage you (the victim or family members or loved ones of victims) to becomes involved and make your voice heard. You can submit articles, letters, news, stories, and suggestions through email @ seroquellawsuitblog@gmail.com

You are not alone, there is power in numbers, we will be heard....change is possible